ObvioHealth
Private Company
Total funding raised: $17.5M
Overview
ObvioHealth, founded in 2017 and based in Orlando, USA, is a private company operating in the Digital Health sector. It has developed the ObvioGo® platform, an end-to-end digital solution for designing and managing decentralized and hybrid clinical trials. The company targets pharmaceutical, biotech, medical device, and CRO clients, offering a suite of tools to reduce trial timelines, improve data quality, and enhance patient compliance. ObvioHealth is in a revenue-generating stage, leveraging a platform-based business model to scale its operations.
Technology Platform
ObvioGo® is an enterprise digital platform for designing and managing decentralized and hybrid clinical trials. It is an integrated suite offering no-code study design, digital recruitment, eConsent with eSignature, logistics management, ePRO/eCOA, virtual visits, and real-time data capture/monitoring, all built for compliance and scalability.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
ObvioHealth competes in a crowded market for decentralized clinical trial solutions. Key competitors include pure-play DCT platform providers like Medable and Science 37, as well as the digital trial arms of large Contract Research Organizations (CROs) such as IQVIA and Parexel. Its differentiation hinges on its position as an integrated, end-to-end platform aiming to simplify sponsor operations.